Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1973 1
1977 1
1980 1
1982 1
1983 1
1984 1
1985 6
1987 5
1988 7
1989 10
1990 10
1991 10
1992 2
1993 5
1994 7
1995 3
1996 7
1997 7
1998 9
1999 13
2000 8
2001 20
2002 19
2003 17
2004 12
2005 16
2006 18
2007 14
2008 27
2009 22
2010 25
2011 38
2012 34
2013 33
2014 57
2015 54
2016 47
2017 40
2018 52
2019 49
2020 48
2021 66
2022 48
2023 51
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

838 results

Results by year

Filters applied: . Clear all
Page 1
Hereditary alpha-tryptasemia.
Bonadonna P, Nalin F, Olivieri F. Bonadonna P, et al. Curr Opin Allergy Clin Immunol. 2022 Oct 1;22(5):277-282. doi: 10.1097/ACI.0000000000000849. Epub 2022 Aug 4. Curr Opin Allergy Clin Immunol. 2022. PMID: 35942852 Review.
It is a risk factor for severe anaphylaxis and an established modifier of mast cell mediator-associated symptoms among patients with systemic mastocytosis (SM). SUMMARY: The unique properties of naturally occurring alpha/beta-tryptase heterotetramers may explain certain el …
It is a risk factor for severe anaphylaxis and an established modifier of mast cell mediator-associated symptoms among patients with systemi …
Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management.
Pardanani A. Pardanani A. Am J Hematol. 2021 Apr 1;96(4):508-525. doi: 10.1002/ajh.26118. Epub 2021 Feb 21. Am J Hematol. 2021. PMID: 33524167 Free article. Review.
OVERVIEW: Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MC) in extra-cutaneous organs. ...
OVERVIEW: Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MC) in extra-cutaneous organs. ...
New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy.
Valent P, Akin C, Sperr WR, Horny HP, Arock M, Metcalfe DD, Galli SJ. Valent P, et al. Annu Rev Pathol. 2023 Jan 24;18:361-386. doi: 10.1146/annurev-pathmechdis-031521-042618. Epub 2022 Oct 21. Annu Rev Pathol. 2023. PMID: 36270293 Free article. Review.
Mastocytosis is a heterogeneous group of neoplasms defined by a numerical increase and accumulation of clonal mast cells (MCs) in various organ systems. The disease may present as cutaneous mastocytosis or systemic mastocytosis (SM). On the basis of histopath …
Mastocytosis is a heterogeneous group of neoplasms defined by a numerical increase and accumulation of clonal mast cells (MCs) in var …
Mastocytosis demystified.
Veitch S, Radia DH. Veitch S, et al. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):396-406. doi: 10.1182/hematology.2023000505. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066855 Review.
Mastocytosis is a rare, clinically heterogenous clonal hematological neoplasm. Over 95% of patients harbor the driver KIT D816V mutation resulting in mast cell (MC) accumulation and proliferation in various organs, leading to variable symptom manifestations that result fro …
Mastocytosis is a rare, clinically heterogenous clonal hematological neoplasm. Over 95% of patients harbor the driver KIT D816V mutat …
Pediatric mastocytosis.
Hussain SH. Hussain SH. Curr Opin Pediatr. 2020 Aug;32(4):531-538. doi: 10.1097/MOP.0000000000000922. Curr Opin Pediatr. 2020. PMID: 32692050 Review.
PURPOSE OF REVIEW: The current article highlights recent developments in the field of pediatric cutaneous mastocytosis. Mastocytosis is a spectrum of conditions that range from fleetingly benign to aggressively malignant. ...KIT mutations are found in the majority o …
PURPOSE OF REVIEW: The current article highlights recent developments in the field of pediatric cutaneous mastocytosis. Mastocytos …
Mastocytosis and Anaphylaxis.
Schuch A, Brockow K. Schuch A, et al. Immunol Allergy Clin North Am. 2017 Feb;37(1):153-164. doi: 10.1016/j.iac.2016.08.017. Epub 2016 Oct 28. Immunol Allergy Clin North Am. 2017. PMID: 27886904 Review.
This article updates current knowledge on epidemiology, risk factors, triggers, and management of anaphylaxis in patients with mastocytosis. Hyperactive mast cells and higher number of effector mast cells are speculated to facilitate anaphylaxis in this condition. ...Hymen …
This article updates current knowledge on epidemiology, risk factors, triggers, and management of anaphylaxis in patients with mastocytos …
Mastocytosis.
Birn CS. Birn CS. Gastroenterol Nurs. 2018 Sep/Oct;41(5):380-387. doi: 10.1097/SGA.0000000000000344. Gastroenterol Nurs. 2018. PMID: 30272600 Review.
Mastocytosis is a rare and underdiagnosed disorder characterized by mast cell proliferation in the tissues and organs of the body. ...Irreversible, with symptoms that run the gamut from the merely annoying to the severely life-threatening, mastocytosis is a disease …
Mastocytosis is a rare and underdiagnosed disorder characterized by mast cell proliferation in the tissues and organs of the body. .. …
Mastocytosis.
Brockow K, Metcalfe DD. Brockow K, et al. Chem Immunol Allergy. 2010;95:110-124. doi: 10.1159/000315946. Epub 2010 Jun 1. Chem Immunol Allergy. 2010. PMID: 20519885 Free PMC article. Review.
Most patients with mastocytosis are recognized by their characteristic skin lesions. An increased level of baseline serum mast cell tryptase is also an indicator for a possible clonal mast cell disorder including mastocytosis. ...As recognition depends on an underst …
Most patients with mastocytosis are recognized by their characteristic skin lesions. An increased level of baseline serum mast cell t …
Mastocytosis.
Abid A, Malone MA, Curci K. Abid A, et al. Prim Care. 2016 Sep;43(3):505-18. doi: 10.1016/j.pop.2016.04.007. Prim Care. 2016. PMID: 27545739 Review.
Clinical presentation is variable, often based on the type of mastocytosis, but in all types of mastocytosis there seems to be an increase in the risk of anaphylaxis. ...There are no therapies that change the natural course of mastocytosis. For cutaneous m …
Clinical presentation is variable, often based on the type of mastocytosis, but in all types of mastocytosis there seems to be …
838 results